Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of China Hematopoietic Stem Cells (HSCs) Market Report & Forecast 2021-2027
1 Introduction to Research & Analysis Reports1.1 Hematopoietic Stem Cells (HSCs) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Hematopoietic Stem Cells (HSCs) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Hematopoietic Stem Cells (HSCs) Overall Market Size
2.1 China Hematopoietic Stem Cells (HSCs) Market Size: 2021 VS 2027
2.2 China Hematopoietic Stem Cells (HSCs) Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hematopoietic Stem Cells (HSCs) Players in China Market
3.2 Top China Hematopoietic Stem Cells (HSCs) Companies Ranked by Revenue
3.3 China Hematopoietic Stem Cells (HSCs) Revenue by Companies
3.4 Top 3 and Top 5 Hematopoietic Stem Cells (HSCs) Companies in China Market, by Revenue in 2020
3.5 Companies Hematopoietic Stem Cells (HSCs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hematopoietic Stem Cells (HSCs) Players in China Market
3.6.1 List of Tier 1 Hematopoietic Stem Cells (HSCs) Companies in China
3.6.2 List of Tier 2 and Tier 3 Hematopoietic Stem Cells (HSCs) Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Hematopoietic Stem Cells (HSCs) Market Size Markets, 2021 & 2027
4.1.2 Leukocyte
4.1.3 Lymphocytes
4.1.4 Red Blood Cells
4.1.5 Platelets
4.2 By Type - China Hematopoietic Stem Cells (HSCs) Revenue & Forecasts
4.2.1 By Type - China Hematopoietic Stem Cells (HSCs) Revenue, 2016-2021
4.2.2 By Type - China Hematopoietic Stem Cells (HSCs) Revenue, 2022-2027
4.2.3 By Type - China Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Hematopoietic Stem Cells (HSCs) Market Size, 2021 & 2027
5.1.2 Blood System Diseases
5.1.3 Autoimmune Diseases
5.1.4 Other
5.2 By Application - China Hematopoietic Stem Cells (HSCs) Revenue & Forecasts
5.2.1 By Application - China Hematopoietic Stem Cells (HSCs) Revenue, 2016-2021
5.2.2 By Application - China Hematopoietic Stem Cells (HSCs) Revenue, 2022-2027
5.2.3 By Application - China Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2016-2027
6 Hematopoietic Stem Cells (HSCs) Companies Profiles
6.1 Kite Pharma Inc.
6.1.1 Kite Pharma Inc. Company Details
6.1.2 Kite Pharma Inc. Business Overview
6.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Introduction
6.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.1.5 Kite Pharma Inc. Recent Developments
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Details
6.2.2 Thermo Fisher Scientific Business Overview
6.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Introduction
6.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.2.5 Thermo Fisher Scientific Recent Developments
6.3 PromoCell
6.3.1 PromoCell Company Details
6.3.2 PromoCell Business Overview
6.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Introduction
6.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.3.5 PromoCell Recent Developments
6.4 CellGenix Technologie Transfer GmbH
6.4.1 CellGenix Technologie Transfer GmbH Company Details
6.4.2 CellGenix Technologie Transfer GmbH Business Overview
6.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Introduction
6.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.4.5 CellGenix Technologie Transfer GmbH Recent Developments
6.5 Cesca Therapeutics Inc.
6.5.1 Cesca Therapeutics Inc. Company Details
6.5.2 Cesca Therapeutics Inc. Business Overview
6.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Introduction
6.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.5.5 Cesca Therapeutics Inc. Recent Developments
6.6 R&D Systems
6.6.1 R&D Systems Company Details
6.6.2 R&D Systems Business Overview
6.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Introduction
6.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.6.5 R&D Systems Recent Developments
6.7 Genlantis
6.7.1 Genlantis Company Details
6.7.2 Genlantis Business Overview
6.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Introduction
6.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.7.5 Genlantis Recent Developments
6.8 Lonza Group Ltd.
6.8.1 Lonza Group Ltd. Company Details
6.8.2 Lonza Group Ltd. Business Overview
6.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Introduction
6.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.8.5 Lonza Group Ltd. Recent Developments
6.9 TiGenix N.V.
6.9.1 TiGenix N.V. Company Details
6.9.2 TiGenix N.V. Business Overview
6.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Introduction
6.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.9.5 TiGenix N.V. Recent Developments
6.10 ScienCell Research Laboratories
6.10.1 ScienCell Research Laboratories Company Details
6.10.2 ScienCell Research Laboratories Business Overview
6.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Introduction
6.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.10.5 ScienCell Research Laboratories Recent Developments
6.11 China Cord Blood Corporation
6.11.1 China Cord Blood Corporation Company Details
6.11.2 China Cord Blood Corporation Business Overview
6.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Introduction
6.11.4 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.11.5 China Cord Blood Corporation Recent Developments
6.12 Vcanbio
6.12.1 Vcanbio Company Details
6.12.2 Vcanbio Business Overview
6.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Introduction
6.12.4 Vcanbio Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.12.5 Vcanbio Recent Developments
6.13 Boyalife
6.13.1 Boyalife Company Details
6.13.2 Boyalife Business Overview
6.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Introduction
6.13.4 Boyalife Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.13.5 Boyalife Recent Developments
6.14 Beike Biotechnology
6.14.1 Beike Biotechnology Company Details
6.14.2 Beike Biotechnology Business Overview
6.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Introduction
6.14.4 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021)
6.14.5 Beike Biotechnology Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Figures, Tables and Charts Available in China Hematopoietic Stem Cells (HSCs) Market Report & Forecast 2021-2027
List of TablesTable 1. Hematopoietic Stem Cells (HSCs) Market Opportunities & Trends in China Market
Table 2. Hematopoietic Stem Cells (HSCs) Market Drivers in China Market
Table 3. Hematopoietic Stem Cells (HSCs) Market Restraints in China Market
Table 4. Key Players of Hematopoietic Stem Cells (HSCs) in China Market
Table 5. Top Hematopoietic Stem Cells (HSCs) Players in China Market, Ranking by Revenue (2019)
Table 6. China Hematopoietic Stem Cells (HSCs) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Hematopoietic Stem Cells (HSCs) Revenue Share by Companies, 2016-2021
Table 8. Companies Hematopoietic Stem Cells (HSCs) Product Type
Table 9. List of Tier 1 Hematopoietic Stem Cells (HSCs) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hematopoietic Stem Cells (HSCs) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – China Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn), 2022-2027
Table 14. By Application – China Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn), 2022-2027
Table 17. Kite Pharma Inc. Company Details
Table 18. Kite Pharma Inc. Business Overview
Table 19. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product
Table 20. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Kite Pharma Inc. Recent Developments
Table 22. Thermo Fisher Scientific Company Details
Table 23. Thermo Fisher Scientific Business Overview
Table 24. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product
Table 25. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. PromoCell Company Details
Table 28. PromoCell Business Overview
Table 29. PromoCell Hematopoietic Stem Cells (HSCs) Product
Table 30. PromoCell Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 31. PromoCell Recent Developments
Table 32. CellGenix Technologie Transfer GmbH Company Details
Table 33. CellGenix Technologie Transfer GmbH Business Overview
Table 34. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product
Table 35. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 36. CellGenix Technologie Transfer GmbH Recent Developments
Table 37. Cesca Therapeutics Inc. Company Details
Table 38. Cesca Therapeutics Inc. Business Overview
Table 39. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product
Table 40. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Cesca Therapeutics Inc. Recent Developments
Table 42. R&D Systems Company Details
Table 43. R&D Systems Business Overview
Table 44. R&D Systems Hematopoietic Stem Cells (HSCs) Product
Table 45. R&D Systems Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 46. R&D Systems Recent Developments
Table 47. Genlantis Company Details
Table 48. Genlantis Business Overview
Table 49. Genlantis Hematopoietic Stem Cells (HSCs) Product
Table 50. Genlantis Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Genlantis Recent Developments
Table 52. Lonza Group Ltd. Company Details
Table 53. Lonza Group Ltd. Business Overview
Table 54. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product
Table 55. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Lonza Group Ltd. Recent Developments
Table 57. TiGenix N.V. Company Details
Table 58. TiGenix N.V. Business Overview
Table 59. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product
Table 60. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 61. TiGenix N.V. Recent Developments
Table 62. ScienCell Research Laboratories Company Details
Table 63. ScienCell Research Laboratories Business Overview
Table 64. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product
Table 65. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 66. ScienCell Research Laboratories Recent Developments
Table 67. China Cord Blood Corporation Company Details
Table 68. China Cord Blood Corporation Business Overview
Table 69. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product
Table 70. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 71. China Cord Blood Corporation Recent Developments
Table 72. Vcanbio Company Details
Table 73. Vcanbio Business Overview
Table 74. Vcanbio Hematopoietic Stem Cells (HSCs) Product
Table 75. Vcanbio Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Vcanbio Recent Developments
Table 77. Boyalife Company Details
Table 78. Boyalife Business Overview
Table 79. Boyalife Hematopoietic Stem Cells (HSCs) Product
Table 80. Boyalife Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 81. Boyalife Recent Developments
Table 82. Beike Biotechnology Company Details
Table 83. Beike Biotechnology Business Overview
Table 84. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product
Table 85. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue in China Market (2016-2021) & (US$ Million)
Table 86. Beike Biotechnology Recent Developments
List of Figures
Figure 1. Hematopoietic Stem Cells (HSCs) Segment by Type
Figure 2. Hematopoietic Stem Cells (HSCs) Segment by Application
Figure 3. China Hematopoietic Stem Cells (HSCs) Market Overview: 2020
Figure 4. China Hematopoietic Stem Cells (HSCs) Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Hematopoietic Stem Cells (HSCs) Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2020
Figure 7. By Type - China Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2016-2027
Figure 8. By Application - China Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2016-2027
Figure 9. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. PromoCell Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. R&D Systems Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Genlantis Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Vcanbio Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Boyalife Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Keyplayers in China Hematopoietic Stem Cells (HSCs) Market Report & Forecast 2021-2027
Kite Pharma Inc.Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
REQUEST COMPANIES MENTIONED IN THIS REPORT
